<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Molecules</journal-id><journal-id journal-id-type="iso-abbrev">Molecules</journal-id><journal-id journal-id-type="publisher-id">molecules</journal-id><journal-title-group><journal-title>Molecules</journal-title></journal-title-group><issn pub-type="epub">1420-3049</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7179133</article-id><article-id pub-id-type="doi">10.3390/molecules25051057</article-id><article-id pub-id-type="publisher-id">molecules-25-01057</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Total Synthesis of (&#x02013;)-Anaferine: A Further Ramification in a Diversity-Oriented Approach</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Bonandi</surname><given-names>Elisa</given-names></name><xref rid="c1-molecules-25-01057" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Tedesco</surname><given-names>Giada</given-names></name></contrib><contrib contrib-type="author"><name><surname>Perdicchia</surname><given-names>Dario</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-6180-9581</contrib-id><name><surname>Passarella</surname><given-names>Daniele</given-names></name><xref rid="c1-molecules-25-01057" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Costantino</surname><given-names>Valeria</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-molecules-25-01057">Universit&#x000e0; degli Studi di Milano, Via Golgi 19, 20133 Milano, Italy; <email>giada.tedesco@oci.uni-hannover.de</email> (G.T.); <email>dario.perdicchia@unimi.it</email> (D.P.)</aff><author-notes><corresp id="c1-molecules-25-01057"><label>*</label>Correspondence: <email>elisa.bonandi@unimi.it</email> (E.B.); <email>daniele.passarella@unimi.it</email> (D.P.); Tel.: +39-025-031-4081 (D.P.)</corresp></author-notes><pub-date pub-type="epub"><day>27</day><month>2</month><year>2020</year></pub-date><pub-date pub-type="collection"><month>3</month><year>2020</year></pub-date><volume>25</volume><issue>5</issue><elocation-id>1057</elocation-id><history><date date-type="received"><day>10</day><month>2</month><year>2020</year></date><date date-type="accepted"><day>26</day><month>2</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 by the authors.</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>The piperidine ring is a widespread motif in several natural bioactive alkaloids of both vegetal and marine origin. In the last years, a diversity-oriented synthetic (DOS) approach, aimed at the generation of a library of piperidine-based derivatives, was developed in our research group, employing commercially available 2-piperidine ethanol as a versatile precursor. Here, we report the exploration of another ramification of our DOS approach, that led us to the stereoselective total synthesis of (&#x02013;)-anaferine, a bis-piperidine alkaloid present in <italic>Withania somnifera</italic> extract. This natural product was obtained in 9% overall yield over 13 steps, starting from a key homoallylic alcohol previously synthesised in our laboratory. Therefore, the collection of piperidine-derivatives accessible from 2-piperidine ethanol was enriched with a new, diverse scaffold.</p></abstract><kwd-group><kwd>bis-piperidine alkaloids</kwd><kwd>anaferine</kwd><kwd>diversity-oriented synthesis</kwd><kwd>2-piperidine ethanol</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-molecules-25-01057"><title>1. Introduction</title><p>Piperidine alkaloids are widespread natural products in the plant kingdom, but they are also present in the animal one, in particular in marine microorganisms [<xref rid="B1-molecules-25-01057" ref-type="bibr">1</xref>]. They are historically known as potent poisons and teratogens: some well-known examples include coniine (from hemlock), lupinine (from lupin flour) and cytisine, contained in <italic>Laburnum</italic> spp. pods [<xref rid="B2-molecules-25-01057" ref-type="bibr">2</xref>]. These effects are mainly the result of the nicotinic acetylcholine receptors (nAChRs) desensitisation [<xref rid="B3-molecules-25-01057" ref-type="bibr">3</xref>]. However, piperidine alkaloids are characterised also by a wide range of interesting biological properties, including anthelminthic (e.g., isopelletierine), antioxidant and neuroprotective activities (e.g., lobeline) and the abilities of increasing drugs bioavailability and of contrasting multidrug resistance (e.g., piperine, lobeline) [<xref rid="B1-molecules-25-01057" ref-type="bibr">1</xref>]. The structures of the mentioned alkaloids are depicted in <xref ref-type="fig" rid="molecules-25-01057-f001">Figure 1</xref>.</p><p>In the marine kingdom, some representative piperidine-containing bioactive compounds, isolated mainly from sponges, are halichlorine (anti-inflammatory, cytotoxic) [<xref rid="B4-molecules-25-01057" ref-type="bibr">4</xref>] and stellettamide B (antifungal and RNA-cleaving activities, from <italic>Stelletta sp</italic>. [<xref rid="B5-molecules-25-01057" ref-type="bibr">5</xref>]) (<xref ref-type="fig" rid="molecules-25-01057-f001">Figure 1</xref>).</p><p>Also several bis-piperidine alkaloids, in which the two heterocycles are embedded in complex macrocyclic systems, are diffused in marine microorganisms. These compounds proved to possess antifungal, antimicrobial properties and cytotoxic activity against different cancer cell lines. Some examples belonging to this class are tetradehydrohalicyclamine A and B, 22-hydroxyhalicyclamine A, haliclonacyclamine A and F, arenosclerins D and E, madangamine F and neopetrosiamine A [<xref rid="B6-molecules-25-01057" ref-type="bibr">6</xref>,<xref rid="B7-molecules-25-01057" ref-type="bibr">7</xref>,<xref rid="B8-molecules-25-01057" ref-type="bibr">8</xref>,<xref rid="B9-molecules-25-01057" ref-type="bibr">9</xref>,<xref rid="B10-molecules-25-01057" ref-type="bibr">10</xref>].</p><p>In this context, we realized that some of the cited natural products shared a common structural motif, constituted by a piperidine ring substituted in the 2-position, generating in this way a defined stereocenter (shown in pink in <xref ref-type="fig" rid="molecules-25-01057-f001">Figure 1</xref>).</p><p>These features seemed quite familiar to us, because they characterised a library of compounds previously synthesised in our laboratory. In fact, the importance of the piperidine ring in bioactive natural products, prompted us to devise a diversity-oriented approach (DOS), aimed at the generation of a diversified library of derivatives containing this key heterocycle. In this project, the ideal starting point to achieve structural diversification proved to be the 2-piperidine ethanol (<bold>1</bold>), a cheap and commercially available racemic product that incorporates the fundamental highlighted 2-substituted-piperidine moiety. Our library is composed by natural products (such as aloperine, coniine, boehmeriasin A and sedum alkaloids [<xref rid="B11-molecules-25-01057" ref-type="bibr">11</xref>,<xref rid="B12-molecules-25-01057" ref-type="bibr">12</xref>,<xref rid="B13-molecules-25-01057" ref-type="bibr">13</xref>,<xref rid="B14-molecules-25-01057" ref-type="bibr">14</xref>]), and synthetic derivatives [<xref rid="B15-molecules-25-01057" ref-type="bibr">15</xref>,<xref rid="B16-molecules-25-01057" ref-type="bibr">16</xref>,<xref rid="B17-molecules-25-01057" ref-type="bibr">17</xref>,<xref rid="B18-molecules-25-01057" ref-type="bibr">18</xref>], as depicted in <xref ref-type="fig" rid="molecules-25-01057-f002">Figure 2</xref>.</p><p>We are currently trying to further enrich our library with new scaffolds. To this end, here we report the synthesis of (&#x02013;)-anaferine starting from <bold>1</bold>, as a further ramification of our DOS approach. </p><p>(&#x02013;)-Anaferine is a bis-piperidine alkaloid, in which the two rings are connected through their C-2 atoms by a 2-propanone bridge. Being C2-symmetrical, this framework exists as two enantiomers and a meso-form. The diastereomeric mixture was isolated for the first time in 1962 [<xref rid="B19-molecules-25-01057" ref-type="bibr">19</xref>] from the root extract of <italic>Withania somnifera</italic>, a plant widely exploited in the Ayurvedic medicine on the basis of several biological properties, including anti-inflammatory, anti-stress, immunomodulatory, adaptogenic, anticancer and neuroprotective activities [<xref rid="B20-molecules-25-01057" ref-type="bibr">20</xref>]. ORD (optical rotary dispersion) analysis led to the determination of the absolute configuration of the two enantiomers: (&#x02013;)-anaferine proved to be the (<italic>R,R</italic>)- enantiomer, and (+)-anaferine the (<italic>S,S</italic>)-one [<xref rid="B21-molecules-25-01057" ref-type="bibr">21</xref>].</p><p>Most of the studies and the synthetic efforts on this topic, date back to the 70s, but in the last years this alkaloid has attracted once again the interest of the scientific community, thanks to <italic>in silico</italic> studies that suggested possible applications in the treatment of neurodegenerative diseases [<xref rid="B22-molecules-25-01057" ref-type="bibr">22</xref>,<xref rid="B23-molecules-25-01057" ref-type="bibr">23</xref>].</p><p>The last total synthesis of (&#x02013;)-anaferine was accomplished in 2002 by Stapper and Blechert [<xref rid="B24-molecules-25-01057" ref-type="bibr">24</xref>], while del Pozo et al. recently reported the preparation of the (+)-enantiomer [<xref rid="B25-molecules-25-01057" ref-type="bibr">25</xref>] (<xref ref-type="fig" rid="molecules-25-01057-f003">Figure 3</xref>).</p><p>Stapper and Blechert&#x02019;s strategy took advantage of an enantiopure cycloheptene precursor, accessed in five steps from the commercially available tropone. Then, after its conversion into the corresponding diamine, a tandem ring rearrangement metathesis, consisting in a ring-opening metathesis, followed by two ring-closing metatheses, afforded the fundamental carbon skeleton, that was transformed into the final product upon reduction of the double bonds, cleavage of the protecting groups and oxidation of the secondary alcohol to ketone (<xref ref-type="fig" rid="molecules-25-01057-f003">Figure 3</xref>A).</p><p>On the other hand, del Pozo&#x02019;s approach involved the double use of <italic>N</italic>-sulfinyl amines, as both chiral auxiliaries and nucleophiles in an intramolecular aza-Michael reaction, as appreciable in <xref ref-type="fig" rid="molecules-25-01057-f003">Figure 3</xref>B. A bidirectional cross metathesis (CM), between the required sulfinyl amine and divinyl ketone gave an intermediate that underwent a double intramolecular aza-Michael reaction, forming the bis-piperidine core and generating at the same time the two stereocenters. Acidic cleavage of the sulfinyl groups led to (+)-anaferine synthesis completion.</p></sec><sec sec-type="results" id="sec2-molecules-25-01057"><title>2. Results and Discussion</title><p>The idea of enriching our DOS library with (&#x02013;)-anaferine was suggested by compound <bold>3</bold> (<xref ref-type="scheme" rid="molecules-25-01057-sch001">Scheme 1</xref>A), previously obtained in our laboratory as an intermediate in the synthesis of the pironetin-dumetorine hybrids shown in <xref ref-type="fig" rid="molecules-25-01057-f002">Figure 2</xref> [<xref rid="B15-molecules-25-01057" ref-type="bibr">15</xref>]. Compound <bold>3</bold> is characterised by a piperidine core, deriving from the 2-piperidine ethanol, by a 2-methoxy propane bridge and by a homoallylic alcohol. The synthesis of <bold>3</bold>, starting from 2-piperidine ethanol is summarized in <xref ref-type="scheme" rid="molecules-25-01057-sch001">Scheme 1</xref>A, and involves as key step the conversion of <bold>1</bold> into the homoallylic alcohol <bold>2a.</bold> Notably, <bold>2a</bold> was recently exploited also for the synthesis of an &#x003b1;,&#x003b2;-unsaturated lactam (compound <bold>5</bold>), as appreciable again in <xref ref-type="scheme" rid="molecules-25-01057-sch001">Scheme 1</xref>A [<xref rid="B18-molecules-25-01057" ref-type="bibr">18</xref>]. Therefore, comparing the two synthetic routes, it&#x02019;s possible to deduce the genesis of our synthetic plan. In fact, we reasoned that an analogue (<bold>8</bold>) of compound <bold>3</bold>, bearing an O-silylether instead of the methoxy group, could have been easily obtained starting from <bold>2a</bold>, taking advantage of the same synthetic strategy. The homoallylic alcohol of <bold>8</bold> could be then converted into lactam <bold>12</bold>, exploiting the same approach employed for the synthesis of <bold>5</bold> from <bold>2a</bold>. The synthesis of (&#x02013;)-anaferine could be completed reducing the <italic>&#x003b1;,&#x003b2;</italic>-unsaturated lactam of <bold>12</bold> to the corresponding piperidine, and oxidizing the secondary alcohol to ketone, as depicted in the forward synthetic <xref ref-type="scheme" rid="molecules-25-01057-sch001">Scheme 1</xref>B. Of course, the synthesis of (&#x02013;)-anaferine requires a strict control over the stereochemistry, in order to access the correct <italic>(R,R</italic>)-enantiomer. To this extent, two asymmetric Brown allylations were considered.</p><p>The proposed synthetic strategy started from the homoallylic alcohol <bold>2a</bold>, previously obtained in our research group from <bold>1</bold> in three steps, involving the protection of the piperidinic nitrogen, oxidation of the alcohol to aldehyde and its asymmetric allylation under Brown&#x02019;s conditions, leading to two diastereomeric alcohols <bold>2a</bold> and <bold>2b</bold> [<xref rid="B18-molecules-25-01057" ref-type="bibr">18</xref>] (<xref ref-type="scheme" rid="molecules-25-01057-sch001">Scheme 1</xref>A). The relative <italic>anti</italic>-configuration of <bold>2a</bold> was established by X-ray analysis, while the desired absolute (<italic>R,S</italic>)-configuration resulted from the use of the proper allylating agent enantiomer (in this case the (&#x02013;)-B-allyl diisopinocampheylborane). In this way, <bold>2a</bold> was obtained with an <italic>e.e.</italic> = 84% (<xref ref-type="app" rid="app1-molecules-25-01057">Supplementary Information, Figure S1</xref>) and was then protected at the hydroxyl group as <italic>tert</italic>-butylsilyl ether (<bold>6</bold>).</p><p>Oxidative cleavage of the double bond afforded aldehyde <bold>7</bold>, that was allylated again exploiting a Brown allylation. Also in this case, the stereocontrol was exerted mainly by the chirality of the Ipc (isopinocampheyl) substituents on the borane, rather than by the stereocenters already present in the substrate. The use of (&#x02013;)-B-allyl diisopinocampheylborane, secured the formation of the desired stereoisomer of compound <bold>8</bold>, that was accessed with a <italic>d.r.</italic>: 85:15. The diastereomeric ratio was determined through <sup>1</sup>H-NMR analysis. In fact, the two possible diastereomers <bold>8</bold> and <bold>8b</bold>, characterized by an opposite configuration at the C-10 stereocenter, were independently synthesised. Their <sup>1</sup>H-NMR spectra in CDCl<sub>3</sub> were almost completely superimposable, rendering impossible the determination of the diastereomeric composition of the reaction mixture obtained under asymmetric conditions. However, we realized that using deuterated benzene a satisfactory signals separation for the two single diastereomers was achieved (<xref ref-type="fig" rid="molecules-25-01057-f004">Figure 4</xref>a, green and red spectra). In this way, once identified the signals of each diastereomers, the <italic>d.r.</italic> of the asymmetric reaction (blue spectrum in <xref ref-type="fig" rid="molecules-25-01057-f004">Figure 4</xref>a) was calculated on the basis of signals integrals, as reported in <xref ref-type="fig" rid="molecules-25-01057-f004">Figure 4</xref>b.</p><p>With the correct stereoisomer of compound <bold>8</bold> in our hands, we proceeded with the following step, that was a Mitsunobu reaction in the presence of diphenylphosphorylazide, that converted the alcohol into the corresponding azide <bold>9</bold>, with inversion of configuration. In this way, the correct (<italic>R</italic>)-configuration of C-10 stereocenter was accessed. Azide reduction under mild Staudinger conditions afforded homoallylic amine <bold>10</bold>. Acylation with the commercially available acryloyl chloride, followed by a ring closing metathesis, led to the formation of the desired &#x003b1;,&#x003b2;-unsaturated lactam <bold>12</bold>. As reported in our previous studies, Umicore M73 SIMes catalyst proved to be the most efficient to favour the ring enclosure [<xref rid="B18-molecules-25-01057" ref-type="bibr">18</xref>,<xref rid="B26-molecules-25-01057" ref-type="bibr">26</xref>]. In this way, the fundamental (&#x02013;)-anaferine carbon skeleton, characterised by two nitrogen-containing hexacycles, connected by the 2-hydroxypropane linker and maintaining the (<italic>R,R</italic>)-configuration of the two key stereocenters, was secured. The next goal was the reduction of the &#x003b1;,&#x003b2;-unsaturated lactam into the corresponding piperidine. First of all, the double bond was selectively reduced through catalytic hydrogenation in the presence of Pd/C. Then, the amidic nitrogen of <bold>13</bold> was protected as Boc [<xref rid="B27-molecules-25-01057" ref-type="bibr">27</xref>] and the piperidone was reduced to piperidine <bold>15,</bold> using BH<sub>3</sub>&#x000b7;SMe<sub>2</sub>. This mild reducing agent was preferred to the most common LiAlH<sub>4</sub>, to avoid the conversion of the two Boc protecting groups into methyl amines [<xref rid="B28-molecules-25-01057" ref-type="bibr">28</xref>]. The TBS protecting group was selectively cleaved using TBAF, affording the known intermediate <bold>16</bold>, reported in Blechert and Stapper&#x02019;s synthesis of (&#x02013;)-anaferine [<xref rid="B24-molecules-25-01057" ref-type="bibr">24</xref>].</p><p>The use of TBAF instead of acid conditions was fundamental to preserve the two Boc protecting groups: this was a mandatory requirement, because two basic nitrogen atoms would have interfered with the following oxidation of the hydroxyl group to ketone. Dess-Martin periodinane (DMP) was employed instead of pyridinium chlorochromate, that was the oxidizing agent of choice in the previously reported synthesis. DMP is a less toxic reagent, easier to handle and that gave, after a basic work-up, the desired product <bold>17</bold> in quantitative yield and without need of further purification. Finally, the cleavage of the two Boc protecting groups in acid environment, led to the desired (-)-anaferine dihydrochloride (<bold>18</bold>), whose identity was confirmed comparing analytical and spectroscopic properties with data reported in literature. The whole synthetic route is depicted in <xref ref-type="scheme" rid="molecules-25-01057-sch002">Scheme 2</xref>.</p><p>In conclusion, 2-piperidine ethanol proved to be once again a flexible synthon for the obtainment of diversified piperidine-containing compounds. In this work, the collection of derivatives previously synthesised in our research group was enriched with (&#x02013;)-anaferine, that was accessed as a new branching of our diversity-oriented approach, with an overall 9% yield over 13 steps. Notably, this strategy could open the possibility of affording interesting analogues of piperidine-based marine and plant-deriving natural products, characterised by a polyketide side chain in C-2 position.</p></sec><sec id="sec3-molecules-25-01057"><title>3. Experimental Section</title><sec id="sec3dot1-molecules-25-01057"><title>3.1. General Remarks</title><p>Unless otherwise stated, reagents and solvents were purchased from Sigma Aldrich (St. Louis, MO, USA), Fluorochem (Zentek, Milano, Italy) or TCI (Zentek, Milano, Italy) and used without further purification. Unless otherwise stated, all reactions were carried out in oven-dried glassware and dry solvents, under nitrogen atmosphere and were monitored by thin layer chromatography (TLC) on silica gel (precoated 60F254 plates, Merck, (Darmstadt, Germany, with detection by UV light (254 nm) or by solutions of potassium permanganate stain, or ninhydrin, or <italic>p</italic>-anisaldehyde stain. Flash chromatography was performed using silica gel (240&#x02212;400 mesh, Merck) as stationary phase.</p><p><sup>1</sup>H-NMR spectra were recorded on an Avance (400 MHz) spectrometer (Bruker, Billerica, MA, USA) and are reported relative to residual CDCl<sub>3</sub> or CD<sub>3</sub>OD. <sup>13</sup>C-NMR spectra were recorded on the same instruments (100 MHz) and are reported relative to residual CDCl<sub>3</sub> or CD<sub>3</sub>OD. All 1D and 2D NMR spectra (Bruker, Billerica, MA, USA) were collected using the standard pulse sequences available with Bruker Topspin 1.3. Chemical shifts (&#x003b4;) for proton and carbon resonances are quoted in parts per million (ppm) relative to tetramethylsilane (TMS), used as an internal standard. Data for <sup>1</sup>H-NMR are reported as follows: chemical shift (&#x003b4;/ppm) (multiplicity, coupling constant (Hz), integration). Multiplicities are reported as follows: s = singlet, d = doublet, t = triplet, m = multiplet, bs = broad singlet. Data for <sup>13</sup>C-NMR are reported in terms of chemical shift (&#x003b4;/ppm).</p><p>Mass spectra were registered exploiting the electrospray ionisation (ESI) technique on a Q-Tof micro mass spectrometer (Waters, Milford, MA, USA).</p><p>Specific rotation values were measured on a P-1030 polarimeter (Jasco, Europe, Cremella, LC, Italy), using 1 mL cells, with path length of 10 cm. Measures were collected at 20&#x02013;25 &#x000b0;C, using sodium D line wavelength &#x003bb; = 589 nm.</p></sec><sec id="sec3dot2-molecules-25-01057"><title>3.2. Synthesis of tert-butyl (2R)-2-[(2S)-2-[(tert-butyldimethylsilyl)oxy]pent-4-en-1-yl]piperidine- 1-carboxylate (<bold><italic>6</italic></bold>)</title><p>TBSCl (0.574 g, 3.81 mmol) was added to a solution of <bold>2a</bold> (0.790 g, 2.93 mmol) and imidazole (0.400 g, 5.86 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (15 mL), previously cooled at 0 &#x000b0;C. The reaction mixture was then diluted with CH<sub>2</sub>Cl<sub>2</sub> and washed with brine. The aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> and the collected organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered and concentrated under vacuum. The crude product was purified by column chromatography on silica gel (hexane: EtOAc = 9:1), to give <bold>6</bold> (1.010 g, 90%) as a yellow oil. [&#x003b1;]<sub>D</sub><sup>20</sup>: +16.9 (<italic>c</italic> = 0.62, CHCl<sub>3</sub>). <sup>1</sup>H-NMR (CDCl<sub>3</sub>) &#x003b4; 5.95&#x02212;5.65 (m, 1H), 5.14&#x02013;4.94 (m, 2H), 4.36&#x02013;4.16 (m, 1H), 4.07&#x02212;3.87 (m, 1H), 3.67 (dq, <italic>J</italic> = 7.6, 5.2 Hz, 1H), 2.86&#x02013;2.63 (m, 1H), 2.50&#x02013;2.31 (m, 1H), 2.31&#x02013;2.16 (m, 1H), 1.83 (m, 1H), 1.75&#x02013;1.47 (m, 7H), 1.46 (s, 9H), 0.98&#x02212;0.79 (m, 9H), 0.07 (s, 3H), 0.06 (s, 3H). <sup>13</sup>C-NMR (CDCl<sub>3</sub>) &#x003b4; 155.0, 135.3, 117.1, 79.4, 69.5, 47.5, 41.2, 39.0, 36.1, 36.8, 29.1, 28.7 (3 CH<sub>3</sub>), 26.0, 25.8 (3 CH<sub>3</sub>), 19.3, &#x02212;4.3 (2 CH<sub>3</sub>). MS (ESI) <italic>m/z</italic> 406.31 [M + Na]<sup>+</sup> (calcd. for C<sub>21</sub>H<sub>41</sub>NO<sub>3</sub>SiNa, 406.27).</p></sec><sec id="sec3dot3-molecules-25-01057"><title>3.3. Synthesis of tert-butyl (2R)-2-[(2R)-2-[(tert-butyldimethylsilyl)oxy]-4-oxobutyl]piperidine- 1-carboxylate (<bold><italic>7</italic></bold>)</title><p>Ozone was fluxed through a solution of <bold>6</bold> (1.000 g, 2.61 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (30 mL), cooled at &#x02212;78 &#x000b0;C. After 1 h, the residual ozone was removed from the solution fluxing nitrogen for 10 min. PPh<sub>3</sub> (1.026 g, 3.91 mmol) was added at &#x02212;78 &#x000b0;C, then the reaction mixture was stirred for 2 h at r.t.. The solvent was removed under vacuum and the residue was purified by column chromatography on silica gel (hexane: EtOAc = 9:1), affording <bold>7</bold> (0.603 g, 60%) as a yellow oil. [&#x003b1;]<sub>D</sub><sup>20</sup>: +22.2 (<italic>c</italic> = 0.52, CHCl<sub>3</sub>). <sup>1</sup>H-NMR (CDCl<sub>3</sub>) &#x003b4; 9.77 (s, 1H), 4.36&#x02212;4.23 (m, 1H), 4.13 (d. quint., <italic>J</italic> = 11.5, 4.2 Hz, 1H), 4.07&#x02212;3.95 (m, 1H), 2.76 (t, <italic>J</italic> = 12.2 Hz, 2H), 2.53 (ddd, <italic>J</italic> = 15.6, 7.0, 3.2 Hz, 1H), 2.14&#x02212;1.97 (m, 1H), 1.56 (dd, <italic>J</italic> = 29.8, 11.2 Hz, 6H), 1.44 (s, 9H), 1.41&#x02212;1.32 (m, 1H), 0.86 (s, 9H), 0.07 (s, 3H), 0.04 (s, 3H). <sup>13</sup>C- NMR (CDCl<sub>3</sub>) &#x003b4; 202.3, 155.0, 79.7, 66.2, 50.4, 47.4, 41.5, 38.2, 29.5, 28.6 (3 CH<sub>3</sub>), 25.9 (3 CH<sub>3</sub>), 25.8, 19.4, 18.1, &#x02212;4.19, &#x02212;4.60. MS (ESI) <italic>m/z</italic> 408.38 [M + Na]<sup>+</sup> (calcd. for C<sub>20</sub>H<sub>39</sub>NO<sub>4</sub>SiNa, 408.25).</p></sec><sec id="sec3dot4-molecules-25-01057"><title>3.4. Synthesis of (R)-tert-butyl 2-((2R,4S)-2-((tert-butyldimethylsilyl)oxy)-4-hydroxyhept-6-en-1-yl) piperidine-1-carboxylate (<bold><italic>8</italic></bold>)</title><p>(-)-DIP-Cl (1.292 g, 4.03 mmol) was dissolved in anhydrous THF (16 mL) and cooled at &#x02212;78 &#x000b0;C. Allylmagnesium bromide (1.0 M solution, 4.14 mL, 4.14 mmol) was added dropwise. The reaction mixture was stirred for 1 h at &#x02212;5 &#x000b0;C and then the white solid was allowed to precipitate. <bold>7</bold> (0.914 g, 2.37 mmol) was dissolved in anhydrous THF (8 mL) and added to the supernatant solution of the previous mixture, cooled at &#x02212;78 &#x000b0;C. After 1 h, the reaction was warmed to r.t. and stirred overnight. The mixture was concentrated and a saturated solution of NaH<sub>2</sub>PO<sub>4</sub> (14mL) was added, followed by MeOH (14 mL) and H<sub>2</sub>O<sub>2</sub> 35% (7mL). The mixture was stirred for 30 min; a saturated solution of NaHCO<sub>3</sub> was added. The layers were separated and the aqueous one was extracted with Et<sub>2</sub>O. The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered and concentrated under vacuum. The crude product was purified by column chromatography on silica gel (hexane: EtOAc = 8:2, second column CH<sub>2</sub>Cl<sub>2</sub>, then CH<sub>2</sub>Cl<sub>2</sub>: MeOH = 95:5), to give <bold>8</bold> (0.932 g, 92%) as light yellow oil. [&#x003b1;]<sub>D</sub><sup>20</sup>: +3.1 (<italic>c</italic> = 0.63, CHCl<sub>3</sub>). <sup>1</sup>H-NMR (CDCl<sub>3</sub>) &#x003b4; 5.86 (m, 1H), 5.17&#x02212;5.02 (m, 2H), 4.36&#x02212;4.20 (m, 1H), 4.15&#x02212;3.91 (m, 1H), 3.91&#x02212;3.76 (m, 2H), 2.78 (t, <italic>J</italic> = 12.7 Hz, 1H), 2.23 (m, 2H), 2.12&#x02212;1.98 (m, 1H), 1.98&#x02212;1.77 (m, 1H), 1.72&#x02212;1.48 (m, 7H), 1.45 (s, 9H), 1.43&#x02212;1.38 (m, 1H), 0.89 (s, 9H), 0.10 (s, 6H). <sup>13</sup>C-NMR (CDCl<sub>3</sub>) &#x003b4; 155.1, 135.2, 117.4, 79.6, 70.7, 70.1, 47.4, 43.7, 42.4, 39.2 (2 CH<sub>2</sub>), 30.0, 28.7 (3CH<sub>3</sub>), 26.0 (3CH<sub>3</sub>), 25.8, 19.4, 18.4, &#x02212;3.9, &#x02212;4.5. MS (ESI) <italic>m/z</italic> 450.79 [M + Na]<sup>+</sup> (calcd. for C<sub>23</sub>H<sub>45</sub>NO<sub>4</sub>SiNa, 450.30).</p></sec><sec id="sec3dot5-molecules-25-01057"><title>3.5. Synthesis of tert-butyl(R)-2-((2R,4R)-4-azido-2-((tert-butyldimethylsilyl)oxy)hept-6-en-1-yl) piperidine-1-carboxylate (<bold><italic>9</italic></bold>)</title><p><bold>8</bold> (0.932 g, 2.18 mmol) and PPh<sub>3</sub> (0.687 g, 2.62 mmol) were dissolved in anhydrous THF (18 mL) and cooled at 0 &#x000b0;C. DIAD (0.52 mL, 2.62 mmol) was added dropwise. The reaction mixture was stirred for 10&#x02032; at 0 &#x000b0;C and then DPPA (0.57 mL, 2.62 mmol) was added dropwise. The reaction was warmed to r.t. and stirred overnight. The mixture was concentrated, and the crude product was purified by column chromatography on silica gel (hexane: EtOAc = 97:3), to give <bold>9</bold> (0.839 g, 85%) as light yellow oil. [&#x003b1;]<sub>D</sub><sup>20</sup>: &#x02212;29.7 (<italic>c</italic> = 0.54, CHCl<sub>3</sub>). <sup>1</sup>H-NMR (CDCl<sub>3</sub>) &#x003b4; 5.82 (ddt, <italic>J</italic> = 17.1, 10.1, 7.0 Hz, 1H), 5.21&#x02212;5.08 (m, 2H), 4.36&#x02212;4.22 (m, 1H), 4.09&#x02212;3.94 (m, 1H), 3.80 (m, 1H), 3.66&#x02212;3.54 (m, 1H), 2.77 (t, <italic>J</italic> = 13.1 Hz, 1H), 2.35 (m, 2H), 2.10&#x02212;1.98 (m, 1H), 1.80&#x02212;1.66 (m, 1H), 1.64&#x02212;1.53 (m, 5H), 1.51 (m, 1H), 1.47 (s, 9H), 1.44&#x02212;1.36 (m, 2H), 0.89 (s, 9H), 0.09 (s, 3H), 0.08 (s, 3H). <sup>13</sup>C-NMR (CDCl<sub>3</sub>) 154.1, 134.1, 118.4, 79.4, 67.2, 58.6, 47.3, 41.1, 39.6, 38.6 (2 CH<sub>2</sub>), 29.8, 28.6 (3 CH<sub>3</sub>), 26.1 (3 CH<sub>3</sub>), 25.8, 19.4, 18.2, &#x02212;3.82, &#x02212;4.69. MS (ESI) <italic>m/z</italic> 475.31 [M + Na]<sup>+</sup> (calcd. for C<sub>23</sub>H<sub>44</sub>N<sub>4</sub>O<sub>3</sub>SiNa, 475.31).</p></sec><sec id="sec3dot6-molecules-25-01057"><title>3.6. Synthesis of (R)-tert-butyl 2-((2S,4R)-4-amino-2-((tert-butyldimethylsilyl)oxy)hept-6-en-1-yl) piperidine-1-carboxylate (<bold><italic>10</italic></bold>)</title><p>Compound <bold>9</bold> (0.821 g, 1.81 mmol) and PPh<sub>3</sub> (0.951 g, 3.63 mmol) were dissolved in a mixture of THF and H<sub>2</sub>O (10:1, 25 mL) and heated at 40 &#x000b0;C for 8 h. At that point, water was added (10.4 mL). The layers were separated and the aqueous one was extracted with Et<sub>2</sub>O. The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered and concentrated under vacuum. The crude product was purified by column chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>: MeOH = 95:5), to give <bold>10</bold> (0.601 g, 78%) as light yellow oil. [&#x003b1;]<sub>D</sub><sup>20</sup>: +6.8 (<italic>c</italic> = 0.46, CHCl<sub>3</sub>). <sup>1</sup>H-NMR (CDCl<sub>3</sub>) &#x003b4; 5.79 (ddt, <italic>J</italic> = 17.2, 10.2, 7.1 Hz, 1H), 5.31&#x02212;4.94 (m, 2H), 4.28&#x02013;4.12 (m, 1H), 4.08&#x02013;3.90 (m, 1H), 3.87&#x02013;3.80 (m, 1H), 3.10&#x02013;3.05 (m, 1H), 2.90&#x02212;2.59 (m, 1H), 2.40&#x02013;2.20 (m, 2H), 2.09&#x02212;2.01 (m, 1H), 1.76&#x02212;1.48 (m, 7H), 1.45 (s, 9H), 1.40&#x02212;1.30 (m, 2H), 0.96&#x02212;0.75 (m, 9H), 0.10&#x02013;&#x02212;0.15 (m, 6H). <sup>13</sup>C-NMR (CDCl<sub>3</sub>) &#x003b4; 155.3, 135.3, 117.9, 79.6, 68.4 (2 CH), 47.8, 42.5 (2 CH<sub>2</sub>), 39.00, 37.8, 29.8, 28.7 (3 CH<sub>3</sub>), 26.0 (3 CH<sub>3</sub>), 25.8, 19.4, 18.1, &#x02212;4.17, &#x02212;4.47. MS (ESI) <italic>m/z</italic> 427.63 [M + H]<sup>+</sup> (calcd. for C<sub>23</sub>H<sub>47</sub>N<sub>2</sub>O<sub>3</sub>Si, 427.33).</p></sec><sec id="sec3dot7-molecules-25-01057"><title>3.7. Synthesis of (R)-tert-butyl 2-((2S,4R)-4-acrylamido-2-((tert-butyldimethylsilyl)oxy) hept-6-en- 1-yl) piperidine-1-carboxylate (<bold><italic>11</italic></bold>)</title><p>Compound <bold>10</bold> (0.558 g, 1.31 mmol) was dissolved in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (5.5 mL) and cooled at 0 &#x000b0;C. Anhydrous TEA (547 &#x003bc;L, 3.92 mmol) was added and the reaction was stirred for 10 min. Acryloyl chloride (160 &#x003bc;L, 1.96 mmol) was added dropwise; the mixture was warmed to r.t. and stirred for 5 h. At that point, cold water (0 &#x000b0;C) was added. The layers were separated and the aqueous one was extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were washed twice with a saturated solution of NH<sub>4</sub>Cl, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered and concentrated under vacuum. The crude product was purified by column chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>: MeOH = 95:5), to give <bold>11</bold> (0.548 g, 88%) as a brown oil. [&#x003b1;]<sub>D</sub><sup>20</sup>: &#x02212;8.1 (<italic>c</italic> = 0.42, CHCl<sub>3</sub>). <sup>1</sup>H-NMR (CDCl<sub>3</sub>) &#x003b4; 6.42 (bs, 1H), 6.29&#x02212;6.03 (m, 2H), 5.81 (ddt, J = 19.2, 9.6, 7.2 Hz, 1H), 5.65&#x02212;5.51 (m, 1H), 5.16&#x02212;4.94 (m, 2H), 4.22&#x02212;4.09 (m, 1H), 4.05&#x02212;3.91 (m, 2H), 3.77&#x02212;3.60 (m, 1H), 2.86 (m, 1H), 2.53&#x02212;2.30 (m, 1H), 2.14&#x02212;2.02 (m, 1H), 1.80 (t, J = 12.8 Hz, 1H), 1.66&#x02212;1.53 (m, 6H), 1.45 (m, 11H), 1.31 (m, 1H), 0.91 (s, 9H), 0.02 (s, 6H). <sup>13</sup>C-NMR (CDCl<sub>3</sub>) &#x003b4; 165.3, 134.6, 131.7, 125.4, 117.4, 79.6, 66.8, 46.6, 39.3 (3CH<sub>2</sub>), 31.4, 30.5 (2CH<sub>2</sub>), 28.6 (3CH<sub>3</sub>), 25.9 (3CH<sub>3</sub>), 25.6, 19.3 (2 CH<sub>2</sub>), 17.9, &#x02212;4.5 (2CH<sub>3</sub>). MS (ESI) <italic>m/z</italic> 503.71 [M + Na]<sup>+</sup> (calcd. for C<sub>26</sub>H<sub>48</sub>N<sub>2</sub>O<sub>4</sub>SiNa, 503.33).</p></sec><sec id="sec3dot8-molecules-25-01057"><title>3.8. Synthesis of (R)-tert-butyl 2-((S)-2-((tert-butyldimethylsilyl)oxy)-3-((R)-6-oxo- 1,2,3,6- tetrahydro-pyridin -2-yl)propyl)piperidine-1-carboxylate (<bold><italic>12</italic></bold>)</title><p>Compound <bold>11</bold> (0.540 g, 1.12 mmol) was dissolved in anhydrous degassed CH<sub>2</sub>Cl<sub>2</sub> (47 mL). A solution of Umicore catalyst 14% wt (59.0 mg, 0.01 mmol) in degassed CH<sub>2</sub>Cl<sub>2</sub> (16.2 mL) was added dropwise and the reaction was stirred for 5 h at 50 &#x000b0;C. The reaction mixture was concentrated under vacuum. The crude product was purified by column chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>: MeOH = 98:2), to give <bold>12</bold> (0.364 g, 71%) as a light yellow oil. [&#x003b1;]<sub>D</sub><sup>20</sup>: +46.2 (<italic>c</italic> = 0.66, CHCl<sub>3</sub>). <sup>1</sup>H-NMR (CDCl<sub>3</sub>) &#x003b4;6.67 (bs, 1H), 6.60&#x02212;6.51 (m, 1H), 5.91&#x02212;5.83 (m, 1H), 4.19 (m, 1H), 3.99&#x02212;3.94 (m, 1H), 3.80&#x02212;3.76 (m, 2H), 2.81&#x02212;2.73 (m, 1H), 2.17&#x02212;2.16 (m, 2H), 1.84-1.75 (m, 2H), 1.54&#x02212;1.46 (m, 6H), 1.45 (s, 9H), 1.36&#x02212;1.28 (m, 2H), 0.89 (s, 9H), 0.06 (s, 6H). <sup>13</sup>C-NMR (CDCl<sub>3</sub>) &#x003b4; 166.0, 155.5, 140.4, 125.2, 79.9, 68.2, 48.0 (2 CH), 31.5 (2 CH<sub>2</sub>), 30.0, 29.8, 28.6 (3 CH<sub>3</sub>), 26.0 (3 CH<sub>3</sub>), 25.9, 25.7, 19.3, 18.1, &#x02212;4.3, &#x02212;4.8. MS (ESI) <italic>m/z</italic> 475.52 [M + Na]<sup>+</sup> (calcd. for C<sub>24</sub>H<sub>44</sub>N<sub>2</sub>O<sub>4</sub>SiNa, 475.30).</p></sec><sec id="sec3dot9-molecules-25-01057"><title>3.9. Synthesis of (R)-tert-butyl 2-((S)-2-((tert-butyldimethylsilyl)oxy)-3-((R)-6- oxopiperidin -2-yl)propyl) piperidine-1-carboxylate (<bold><italic>13</italic></bold>)</title><p>Compound <bold>12</bold> (0.205 g, 0.45 mmol) was dissolved in MeOH (10 mL); Pd/C 10% wt (0.205 g) was added, and the reaction mixture was put under H<sub>2</sub> atmosphere and stirred overnight. The mixture was filtered over Celite, washed with MeOH and CH<sub>2</sub>Cl<sub>2</sub> and concentrated to give <bold>13</bold> (0.206 g, quant.) as a dark yellow oil. [&#x003b1;]<sub>D</sub><sup>20</sup>: +1.4 (<italic>c</italic> = 0.70, CHCl<sub>3</sub>). <sup>1</sup>H-NMR (CDCl<sub>3</sub>) &#x003b4; 6.73 (s, 1H), 4.23&#x02212;4.19 (m, 1H), 4.00&#x02212;3.96 (m, 1H), 3.82&#x02212;3.77 (m, 1H), 3.59&#x02212;3.54 (m, 1H), 2.78 (t, <italic>J</italic> = 13.2 Hz, 1H), 2.44&#x02212;2.32 (m, 1H), 2.25 (ddd, <italic>J</italic> = 17.7, 11.1, 6.5 Hz, 1H), 2.07 (ddd, J = 14.6, 11.4, 3.7 Hz, 1H), 1.88 (m, 1H), 1.84&#x02212;1.66 (m, 4H), 1.66&#x02212;1.48 (m, 6H), 1.45 (s, 9H), 1.37 (m, 2H), 0.91 (s, 9H), 0.08 (s, 6H). <sup>13</sup>C-NMR (CDCl<sub>3</sub>) &#x003b4; 171.6, 155.2, 79.8, 68.6, 49.9, 47.7, 41.5, 39.2, 31.3, 30.3, 30.0, 29.9, 28.7 (3 CH<sub>3</sub>), 26.1 (3 CH<sub>3</sub>), 25.8, 20.6, 19.4, 18.2, &#x02212;4.59, &#x02212;4.91. MS (ESI) <italic>m/z</italic> 477.91 [M + Na]<sup>+</sup> (calcd. for C<sub>24</sub>H<sub>46</sub>N<sub>2</sub>O<sub>4</sub>SiNa, 477.31).</p></sec><sec id="sec3dot10-molecules-25-01057"><title>3.10. Synthesis of (R)-tert-butyl 2-((R)-3-((R)-1-(tert-butoxy carbonyl)piperidin-2-yl)-2- ((tert-butyl-dimethylsilyl)oxy)propyl)-6-oxopiperidine-1-carboxylate (<bold><italic>14</italic></bold>)</title><p>Compound <bold>13</bold> (0.206 g, 0.45 mmol) was dissolved in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (1.5 mL) and cooled to 0 &#x000b0;C. TEA (190 &#x003bc;L, 1.36 mmol), DMAP (0.012 g, 0.09 mmol) and Boc<sub>2</sub>O (0.298 g, 1.36 mmol) were added. The mixture was stirred at r.t. for 48 h and concentrated under vacuum. The crude product was purified by column chromatography on silica gel (hexane: EtOAc = 7:3), to give <bold>14</bold> (0.204 g, 82%) as a dark yellow oil. [&#x003b1;]<sub>D</sub><sup>20</sup>: +23.2 (<italic>c</italic> = 0.82, CHCl<sub>3</sub>). <sup>1</sup>H-NMR (CDCl<sub>3</sub>) &#x003b4; 4.48&#x02212;4.33 (m, 1H), 4.23 (m, 1H), 4.08&#x02212;3.92 (m, 1H), 3.78 (quint., <italic>J</italic> = 6.2 Hz, 1H), 2.77 (t, <italic>J</italic> = 12.7 Hz, 1H), 2.55&#x02212;2.38 (m, 2H), 1.96&#x02212;1.70 (m, 7H), 1.88- 1.56 (m, 5H), 1.52 (s, 9H), 1.44 (s, 9H), 1.31&#x02212;1.19 (m, 2H), 0.88 (s, 9H), 0.07 (s, 6H). <sup>13</sup>C-NMR (CDCl<sub>3</sub>) &#x003b4; 171.3, 154.8, 152.8, 82.9, 79.2, 68.5, 53.7, 47.3, 41.6, 39.2, 36.7, 34.1, 29.7, 28.6 (3 CH<sub>3</sub>), 28.0 (3 CH<sub>3</sub>), 26.7, 25.9 (3 CH<sub>3</sub>), 25.6, 19.2, 17.9, 17.1, &#x02212;4.3 (2 CH<sub>3</sub>). MS (ESI) <italic>m/z</italic> 577.48 [M + Na]<sup>+</sup> (calcd. for C<sub>29</sub>H<sub>54</sub>N<sub>2</sub>O<sub>6</sub>SiNa: 577.36).</p></sec><sec id="sec3dot11-molecules-25-01057"><title>3.11. Synthesis of (2R,2&#x02032;R)-di-tert-butyl 2,2&#x02032;-(2-((tert-butyldimethylsilyl)oxy)propane- 1,3-diyl) bis (piperidine-1-carboxylate) (<bold><italic>15</italic></bold>)</title><p>Compound <bold>14</bold> (0.170 g, 0.31 mmol) was dissolved in anhydrous THF (7.5 mL) and cooled to 0 &#x000b0;C. BH<sub>3</sub>&#x02219;SMe<sub>2</sub> (68 &#x003bc;L, 0.67 mmol), was added dropwise. The mixture was stirred at r.t. for 5h and quenched with a saturated solution of NH<sub>4</sub>Cl. The layers were separated, and the organic one was extracted with Et<sub>2</sub>O. The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered and concentrated under vacuum. The crude product was purified by column chromatography on silica gel (hexane: EtOAc = 8:2), to give <bold>15</bold> (0.126 g, 76%) as a yellow oil. [&#x003b1;]<sub>D</sub><sup>20</sup>: +28.0 (<italic>c</italic> = 0.48, CHCl<sub>3</sub>). <sup>1</sup>H-NMR (CDCl<sub>3</sub>) &#x003b4; 4.40&#x02013;4.24 (m, 2H), 4.00&#x02013;3.87 (m, 2H), 3.72&#x02013;3.61 (m, 1H), 2.84&#x02013;2.71 (m, 2H), 1.94&#x02013;1.63 (m, 6H), 1.60&#x02013;1.51 (m, 6H), 1.45 (s, 18H), 1.39&#x02013;1.34 (m, 4H), 0.89 (s, 9H), 0.06 (s, 6H). <sup>13</sup>C-NMR (CDCl<sub>3</sub>) &#x003b4; 154.9 (2 Cq), 79.1 (2 Cq), 68.7, 47.4 (2 CH), 39.5 (2 CH<sub>2</sub>), 37.6 (2 CH<sub>2</sub>), 29.68 (2 CH<sub>2</sub>), 28.5 (6 CH<sub>3</sub>), 25.7 (3 CH<sub>3</sub>), 25.6 (2 CH<sub>2</sub>), 19.1 (2 CH<sub>2</sub>), 18.01, &#x02212;4.2, &#x02212;4.4. MS (ESI) <italic>m/z</italic> 563.99 [M + Na]<sup>+</sup> (calcd. for C<sub>29</sub>H<sub>56</sub>N<sub>2</sub>O<sub>5</sub>SiNa, 563.38).</p></sec><sec id="sec3dot12-molecules-25-01057"><title>3.12. Synthesis of (2R,2&#x02032;R)-di-tert-butyl 2,2&#x02032;-(2-hydroxypropane-1,3- diyl)bis(piperidine-1-carboxylate) (<bold><italic>16</italic></bold>)</title><p>Compound <bold>15</bold> (0.112g, 0.21 mmol) was dissolved in anhydrous THF (1.5 mL) and cooled to &#x02212;15 &#x000b0;C. TBAF 1.0 M in THF (620 &#x003bc;L, 0.62 mmol), was added dropwise. The mixture was stirred for 16h, slowly warming to 0 &#x000b0;C. The mixture was quenched with a saturated solution of NH<sub>4</sub>Cl. The layers were separated, and the organic one was extracted with Et<sub>2</sub>O. The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered and concentrated under vacuum. The crude product was purified by column chromatography on silica gel (hexane: EtOAc = 85:15), to give <bold>16</bold> (0.090 g, 71%) as a white solid. [&#x003b1;]<sub>D</sub><sup>20</sup>: +43.3 (<italic>c</italic> = 0.53, CHCl<sub>3</sub>). Ref: [&#x003b1;]<sub>D</sub><sup>20</sup>: +41.4 (<italic>c</italic> = 0.72, CHCl<sub>3</sub>). <sup>1</sup>H-NMR (CDCl<sub>3</sub>) &#x003b4; = 4.28&#x02212;4.52 (m, 2 H), 3.70&#x02212;3.98 (m, 2 H), 3.08&#x02212;3.34 (m, 1 H), 2.60&#x02212;2.92 (m, 2 H), 1.80&#x02212;2.38 (m, 2 H), 1.00&#x02212;1.74 (m, 14 H), 1.42 (s, 18 H). <sup>13</sup>C-NMR (CDCl<sub>3</sub>) &#x003b4; = 156.5, 155.0, 79.9, 79.0, 64.7, 47.4, 46.3, 39.3, 39.0, 37.0, 36.7, 29.7, 29.4, 28.5 (3 CH<sub>3</sub>), 28.3 (3 CH<sub>3</sub>), 25.6, 25.5, 19.1 (detected signals). MS (ESI) <italic>m/z</italic> 449.71 [M + Na]<sup>+</sup> (calcd. for C<sub>23</sub>H<sub>42</sub>N<sub>2</sub>O<sub>5</sub>Na, 449.30).</p></sec><sec id="sec3dot13-molecules-25-01057"><title>3.13. Synthesis of (2R,2&#x02032;R)-di-tert-butyl 2,2&#x02032;-(2-oxopropane-1,3-diyl)bis(piperidine-1- carboxylate) (<bold><italic>17</italic></bold>)</title><p>Compound <bold>16</bold> (0.043 g, 0.10 mmol) was dissolved in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (1 mL) at 0 &#x000b0;C, and DMP (50.7 mg, 0.12 mmol) was added. The mixture was stirred for 16h at r.t. The mixture was concentrated; a 10% solution of NaOH was added and the aqueous phase was extracted with Et<sub>2</sub>O. The combined organic layers were washed with NaOH (10%) and H<sub>2</sub>O. The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered and concentrated under vacuum, to give <bold>17</bold> (0.042 g, quant.) as a colourless solid. [&#x003b1;]<sub>D</sub><sup>20</sup>: +19.9 (<italic>c</italic> = 0.77, CHCl<sub>3</sub>). <sup>1</sup>H-NMR (CDCl<sub>3</sub>) &#x003b4; = 4.60&#x02212;4.76 (m, 2 H), 3.82&#x02212;4.02 (m, 2H), 2.50&#x02212;2.86 (m, 6 H), 1.20&#x02212;1.71 (m, 12 H), 1.41 (s, 18 H). <sup>13</sup>C-NMR (CDCl<sub>3</sub>) &#x003b4; 207.2, 154.8 (2 Cq), 79.6 (2 Cq), 47.3 (2 CH), 43.4 (2 CH<sub>2</sub>), 39.6 (2 CH<sub>2</sub>), 28.5 (6 CH<sub>3</sub>), 28.4 (2 CH<sub>2</sub>), 25.4 (2 CH<sub>2</sub>), 19.1 (2 CH<sub>2</sub>). MS (ESI) <italic>m/z</italic> 447.81 [M + Na]<sup>+</sup> (calcd. for C<sub>23</sub>H<sub>40</sub>N<sub>2</sub>O<sub>5</sub>Na, 447.28).</p></sec><sec id="sec3dot14-molecules-25-01057"><title>3.14. Synthesis of 1,3-di((R)-piperidin-2-yl)propan-2-one (<bold><italic>18</italic></bold>)</title><p>Compound <bold>17</bold> (0.030 g, 0.07 mmol) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) and cooled to 0 &#x000b0;C. A 4M solution of HCl (75 &#x003bc;L, 0.21 mmol) in dioxane was added dropwise. The mixture was stirred for 16h at r.t. The mixture was concentrated to give (&#x02013;)-anaferine dihydrochloride (<bold>18</bold>, 0.021 g, quant.) as a colourless solid, without need of further purification. [&#x003b1;]<sub>D</sub><sup>20</sup>: &#x02212;47.9 (<italic>c</italic> = 0.65, MeOH/H<sub>2</sub>O = 1:1). <sup>1</sup>H NMR (CD<sub>3</sub>OD) &#x003b4; = 3.50&#x02212;3.61 (m, 2 H), 3.32&#x02212;3.40 (m, 2 H), 2.88&#x02212;3.05 (m, 6 H), 1.82&#x02212;1.95 (m, 6 H), 1.00&#x02212;1.74 (m, 6 H). <sup>13</sup>C-NMR (CD<sub>3</sub>OD) &#x003b4; = 205.0, 52.3 (2 CH), 44.8 (2CH<sub>2</sub>), 44.7 (2CH<sub>2</sub>), 28.3 (2CH<sub>2</sub>), 22.0 (2CH<sub>2</sub>), 21.6 (2CH<sub>2</sub>). MS (ESI) <italic>m/z</italic> 224.31 [C<sub>13</sub>H<sub>24</sub>N<sub>2</sub>O]<sup>+</sup> (calcd. for C<sub>13</sub>H<sub>24</sub>N<sub>2</sub>O, 224.19).</p></sec></sec></body><back><fn-group><fn><p><bold>Sample Availability:</bold> Samples of the compounds <bold>1</bold>, <bold>2a</bold>, <bold>6</bold>, <bold>8</bold>, <bold>18</bold> are available from the authors.</p></fn></fn-group><app-group><app id="app1-molecules-25-01057"><title>Supplementary Materials</title><supplementary-material content-type="local-data" id="molecules-25-01057-s001"><media xlink:href="molecules-25-01057-s001.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><p>Figure S1: Chiral HPLC analysis for the determination of the <italic>e.e.</italic> of compound <bold>2a</bold>.</p></app></app-group><notes><title>Author Contributions</title><p>Conceptualization, D.P. (Daniele Passarella), E.B.; methodology, E.B., D.P. (Dario Perdicchia); investigation, G.T., E.B.; resources, D.P. (Daniele Passarella); data curation, E.B., G.T.; writing&#x02014;original draft preparation, E.B.; writing&#x02014;review and editing, E.B., G.T., D.P. (Dario Perdicchia); D.P. (Daniele Passarella); supervision, D.P. (Daniele Passarella); project administration, D.P. (Daniele Passarella); funding acquisition, D.P. (Daniele Passarella). All authors have read and agree to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>This research was partially funded by MAECI Italia-India Strategic Projects 2017-2019 MAE0105301 &#x0201c;Development of nature inspired bivalent antitubulins as anticancer agents&#x0201d;.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.</p></notes><ref-list><title>References</title><ref id="B1-molecules-25-01057"><label>1.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Sz&#x00151;ke</surname><given-names>&#x000c9;.</given-names></name><name><surname>Lemberkovics</surname><given-names>&#x000c9;.</given-names></name><name><surname>Kursinszki</surname><given-names>L.</given-names></name></person-group><article-title>Alkaloids Derived from Lysine: Piperidine Alkaloids</article-title><source>Natural Products: Phytochemistry, Botany and Metabolism of Alkaloids, Phenolics and Terpenes</source><publisher-name>Springer</publisher-name><publisher-loc>Berlin/Heidelberg, Germany</publisher-loc><year>2013</year><fpage>303</fpage><lpage>341</lpage></element-citation></ref><ref id="B2-molecules-25-01057"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>B.T.</given-names></name><name><surname>Lee</surname><given-names>S.T.</given-names></name><name><surname>Panter</surname><given-names>K.E.</given-names></name><name><surname>Brown</surname><given-names>D.R.</given-names></name></person-group><article-title>Piperidine Alkaloids: Human and Food Animal Teratogens</article-title><source>Food Chem. Toxicol.</source><year>2012</year><volume>50</volume><fpage>2049</fpage><lpage>2055</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2012.03.049</pub-id><pub-id pub-id-type="pmid">22449544</pub-id></element-citation></ref><ref id="B3-molecules-25-01057"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>B.T.</given-names></name><name><surname>Lee</surname><given-names>S.T.</given-names></name><name><surname>Panter</surname><given-names>K.E.</given-names></name><name><surname>Welch</surname><given-names>K.D.</given-names></name><name><surname>Cook</surname><given-names>D.</given-names></name><name><surname>Pfister</surname><given-names>J.A.</given-names></name><name><surname>Kem</surname><given-names>W.R.</given-names></name></person-group><article-title>Actions of Piperidine Alkaloid Teratogens at Fetal Nicotinic Acetylcholine Receptors</article-title><source>Neurotoxicol. Teratol.</source><year>2010</year><volume>32</volume><fpage>383</fpage><lpage>390</lpage><pub-id pub-id-type="doi">10.1016/j.ntt.2010.01.011</pub-id><?supplied-pmid 20116429?><pub-id pub-id-type="pmid">20116429</pub-id></element-citation></ref><ref id="B4-molecules-25-01057"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>D.</given-names></name><name><surname>Acharya</surname><given-names>H.P.</given-names></name><name><surname>Yu</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Yeh</surname><given-names>V.S.C.</given-names></name><name><surname>Kang</surname><given-names>S.</given-names></name><name><surname>Chiruta</surname><given-names>C.</given-names></name><name><surname>Jachak</surname><given-names>S.M.</given-names></name><name><surname>Clive</surname><given-names>D.L.J.</given-names></name></person-group><article-title>Total Synthesis of the Marine Alkaloid Halichlorine: Development and Use of a General Route to Chiral Piperidines</article-title><source>J. Org. Chem.</source><year>2009</year><volume>74</volume><fpage>7417</fpage><lpage>7428</lpage><pub-id pub-id-type="doi">10.1021/jo901481n</pub-id><?supplied-pmid 19739615?><pub-id pub-id-type="pmid">19739615</pub-id></element-citation></ref><ref id="B5-molecules-25-01057"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamazaki</surname><given-names>N.</given-names></name><name><surname>Dokoshi</surname><given-names>W.</given-names></name><name><surname>Kibayashi</surname><given-names>C.</given-names></name></person-group><article-title>Total Synthesis of (-)-Stellettamide B and Determination of Its Absolute Stereochemistry</article-title><source>Org. Lett.</source><year>2001</year><volume>3</volume><fpage>193</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1021/ol0003228</pub-id><?supplied-pmid 11430032?><pub-id pub-id-type="pmid">11430032</pub-id></element-citation></ref><ref id="B6-molecules-25-01057"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsunaga</surname><given-names>S.</given-names></name><name><surname>Miyata</surname><given-names>Y.</given-names></name><name><surname>Van Soest</surname><given-names>R.W.M.</given-names></name><name><surname>Fusetani</surname><given-names>N.</given-names></name></person-group><article-title>Tetradehydrohalicyclamine A and 22-Hydroxyhalicyclamine A, New Cytotoxic Bis-Piperidine Alkaloids from a Marine Sponge Amphimedon sp.</article-title><source>J. Nat. Prod.</source><year>2004</year><volume>67</volume><fpage>1758</fpage><lpage>1760</lpage><pub-id pub-id-type="doi">10.1021/np049824a</pub-id><?supplied-pmid 15497958?><pub-id pub-id-type="pmid">15497958</pub-id></element-citation></ref><ref id="B7-molecules-25-01057"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Esposito</surname><given-names>G.</given-names></name><name><surname>Mai</surname><given-names>L.H.</given-names></name><name><surname>Longeon</surname><given-names>A.</given-names></name><name><surname>Mangoni</surname><given-names>A.</given-names></name><name><surname>Durieu</surname><given-names>E.</given-names></name><name><surname>Meijer</surname><given-names>L.</given-names></name><name><surname>Van Soest</surname><given-names>R.</given-names></name><name><surname>Costantino</surname><given-names>V.</given-names></name><name><surname>Bourguet-Kondracki</surname><given-names>M.-L.</given-names></name></person-group><article-title>A Collection of Bioactive Nitrogen-Containing Molecules from the Marine Sponge Acanthostrongylophora Ingens</article-title><source>Mar. Drugs</source><year>2019</year><volume>17</volume><elocation-id>472</elocation-id><pub-id pub-id-type="doi">10.3390/md17080472</pub-id></element-citation></ref><ref id="B8-molecules-25-01057"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Oliveira</surname><given-names>J.H.H.L.</given-names></name><name><surname>Nascimento</surname><given-names>A.M.</given-names></name><name><surname>Kossuga</surname><given-names>M.H.</given-names></name><name><surname>Cavalcanti</surname><given-names>B.C.</given-names></name><name><surname>Pessoa</surname><given-names>C.O.</given-names></name><name><surname>Moraes</surname><given-names>M.O.</given-names></name><name><surname>Macedo</surname><given-names>M.L.</given-names></name><name><surname>Ferreira</surname><given-names>A.G.</given-names></name><name><surname>Hajdu</surname><given-names>E.</given-names></name><name><surname>Pinheiro</surname><given-names>U.S.</given-names></name><etal/></person-group><article-title>Cytotoxic Alkylpiperidine Alkaloids from the Brazilian Marine Sponge Pachychalina Alcaloidifera</article-title><source>J. Nat. Prod.</source><year>2007</year><volume>70</volume><fpage>538</fpage><lpage>543</lpage><pub-id pub-id-type="doi">10.1021/np060450q</pub-id><pub-id pub-id-type="pmid">17346073</pub-id></element-citation></ref><ref id="B9-molecules-25-01057"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banwell</surname><given-names>M.G.</given-names></name><name><surname>Coster</surname><given-names>M.J.</given-names></name><name><surname>Hungerford</surname><given-names>N.L.</given-names></name><name><surname>Garson</surname><given-names>M.J.</given-names></name><name><surname>Su</surname><given-names>S.</given-names></name><name><surname>Kotze</surname><given-names>A.C.</given-names></name><name><surname>Munro</surname><given-names>M.H.G.</given-names></name></person-group><article-title>3,4&#x02032;-Linked Bis(Piperidines) Related to the Haliclonacyclamine Class of Marine Alkaloids: Synthesis Using Crossed-Aldol Chemistry and Preliminary Biological Evaluations</article-title><source>Org. Biomol. Chem.</source><year>2012</year><volume>10</volume><fpage>154</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1039/C1OB06418E</pub-id><pub-id pub-id-type="pmid">22068547</pub-id></element-citation></ref><ref id="B10-molecules-25-01057"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>X.</given-names></name><name><surname>Nieves</surname><given-names>K.</given-names></name><name><surname>Rodr&#x000ed;guez</surname><given-names>A.D.</given-names></name></person-group><article-title>Neopetrosiamine A, Biologically Active Bis-Piperidine Alkaloid from the Caribbean Sea Sponge Neopetrosia Proxima</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2010</year><volume>20</volume><fpage>5905</fpage><lpage>5908</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2010.07.084</pub-id><pub-id pub-id-type="pmid">20727745</pub-id></element-citation></ref><ref id="B11-molecules-25-01057"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perdicchia</surname><given-names>D.</given-names></name><name><surname>Christodoulou</surname><given-names>M.</given-names></name><name><surname>Fumagalli</surname><given-names>G.</given-names></name><name><surname>Calogero</surname><given-names>F.</given-names></name><name><surname>Marucci</surname><given-names>C.</given-names></name><name><surname>Passarella</surname><given-names>D.</given-names></name></person-group><article-title>Enzymatic Kinetic Resolution of 2-Piperidineethanol for the Enantioselective Targeted and Diversity Oriented Synthesis</article-title><source>Int. J. Mol. Sci.</source><year>2016</year><volume>17</volume><elocation-id>17</elocation-id><pub-id pub-id-type="doi">10.3390/ijms17010017</pub-id></element-citation></ref><ref id="B12-molecules-25-01057"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christodoulou</surname><given-names>M.S.</given-names></name><name><surname>Calogero</surname><given-names>F.</given-names></name><name><surname>Baumann</surname><given-names>M.</given-names></name><name><surname>Garc&#x000ed;a-Arg&#x000e1;ez</surname><given-names>A.N.</given-names></name><name><surname>Pieraccini</surname><given-names>S.</given-names></name><name><surname>Sironi</surname><given-names>M.</given-names></name><name><surname>Dapiaggi</surname><given-names>F.</given-names></name><name><surname>Bucci</surname><given-names>R.</given-names></name><name><surname>Broggini</surname><given-names>G.</given-names></name><name><surname>Gazzola</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Boehmeriasin A as New Lead Compound for the Inhibition of Topoisomerases and SIRT2</article-title><source>Eur. J. Med. Chem.</source><year>2015</year><volume>92</volume><fpage>766</fpage><lpage>775</lpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2015.01.038</pub-id><?supplied-pmid 25626146?><pub-id pub-id-type="pmid">25626146</pub-id></element-citation></ref><ref id="B13-molecules-25-01057"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barilli</surname><given-names>A.</given-names></name><name><surname>Belinghieri</surname><given-names>F.</given-names></name><name><surname>Passarella</surname><given-names>D.</given-names></name><name><surname>Lesma</surname><given-names>G.</given-names></name><name><surname>Riva</surname><given-names>S.</given-names></name><name><surname>Silvani</surname><given-names>A.</given-names></name><name><surname>Danieli</surname><given-names>B.</given-names></name></person-group><article-title>Enzyme Assisted Enantioselective Synthesis of the Alkaloid (+)-Aloperine</article-title><source>Tetrahedron Asymmetry</source><year>2004</year><volume>15</volume><fpage>2921</fpage><lpage>2925</lpage><pub-id pub-id-type="doi">10.1016/j.tetasy.2004.06.056</pub-id></element-citation></ref><ref id="B14-molecules-25-01057"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riva</surname><given-names>E.</given-names></name><name><surname>Rencurosi</surname><given-names>A.</given-names></name><name><surname>Gagliardi</surname><given-names>S.</given-names></name><name><surname>Passarella</surname><given-names>D.</given-names></name><name><surname>Martinelli</surname><given-names>M.</given-names></name></person-group><article-title>Synthesis of (+)-Dumetorine and Congeners by Using Flow Chemistry Technologies</article-title><source>Chem. A Eur. J.</source><year>2011</year><volume>17</volume><fpage>6221</fpage><lpage>6226</lpage><pub-id pub-id-type="doi">10.1002/chem.201100300</pub-id><?supplied-pmid 21506188?><pub-id pub-id-type="pmid">21506188</pub-id></element-citation></ref><ref id="B15-molecules-25-01057"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marucci</surname><given-names>C.</given-names></name><name><surname>Christodoulou</surname><given-names>M.S.</given-names></name><name><surname>Pieraccini</surname><given-names>S.</given-names></name><name><surname>Sironi</surname><given-names>M.</given-names></name><name><surname>Dapiaggi</surname><given-names>F.</given-names></name><name><surname>Cartelli</surname><given-names>D.</given-names></name><name><surname>Calogero</surname><given-names>A.M.</given-names></name><name><surname>Cappelletti</surname><given-names>G.</given-names></name><name><surname>Vilanova</surname><given-names>C.</given-names></name><name><surname>Gazzola</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Synthesis of Pironetin-Dumetorine Hybrids as Tubulin Binders</article-title><source>Eur. J. Org. Chem.</source><year>2016</year><volume>2016</volume><fpage>2029</fpage><lpage>2036</lpage><pub-id pub-id-type="doi">10.1002/ejoc.201600130</pub-id></element-citation></ref><ref id="B16-molecules-25-01057"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borsini</surname><given-names>E.</given-names></name><name><surname>Broggini</surname><given-names>G.</given-names></name><name><surname>Colombo</surname><given-names>F.</given-names></name><name><surname>Khansaa</surname><given-names>M.</given-names></name><name><surname>Fasana</surname><given-names>A.</given-names></name><name><surname>Galli</surname><given-names>S.</given-names></name><name><surname>Passarella</surname><given-names>D.</given-names></name><name><surname>Riva</surname><given-names>E.</given-names></name><name><surname>Riva</surname><given-names>S.</given-names></name></person-group><article-title>Enantiopure 2-Piperidylacetaldehyde as a Useful Building Block in the Diversity-Oriented Synthesis of Polycyclic Piperidine Derivatives</article-title><source>Tetrahedron Asymmetry</source><year>2011</year><volume>22</volume><fpage>264</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1016/j.tetasy.2011.01.008</pub-id></element-citation></ref><ref id="B17-molecules-25-01057"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonandi</surname><given-names>E.</given-names></name><name><surname>Foschi</surname><given-names>F.</given-names></name><name><surname>Marucci</surname><given-names>C.</given-names></name><name><surname>Dapiaggi</surname><given-names>F.</given-names></name><name><surname>Sironi</surname><given-names>M.</given-names></name><name><surname>Pieraccini</surname><given-names>S.</given-names></name><name><surname>Christodoulou</surname><given-names>M.S.</given-names></name><name><surname>de As&#x000ed;s Balaguer</surname><given-names>F.</given-names></name><name><surname>D&#x000ed;az</surname><given-names>J.F.</given-names></name><name><surname>Zidar</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Synthesis of Thicolchicine-Based Conjugates: Investigation towards Bivalent Tubulin/Microtubules Binders</article-title><source>ChemPlusChem</source><year>2019</year><volume>84</volume><fpage>98</fpage><lpage>102</lpage><pub-id pub-id-type="doi">10.1002/cplu.201800497</pub-id><pub-id pub-id-type="pmid">31950734</pub-id></element-citation></ref><ref id="B18-molecules-25-01057"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonandi</surname><given-names>E.</given-names></name><name><surname>Marzullo</surname><given-names>P.</given-names></name><name><surname>Foschi</surname><given-names>F.</given-names></name><name><surname>Perdicchia</surname><given-names>D.</given-names></name><name><surname>Presti</surname><given-names>L.L.</given-names></name><name><surname>Sironi</surname><given-names>M.</given-names></name><name><surname>Pieraccini</surname><given-names>S.</given-names></name><name><surname>Gambacorta</surname><given-names>G.</given-names></name><name><surname>Saupe</surname><given-names>J.</given-names></name><name><surname>Dalla Via</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Stereodivergent Diversity-Oriented Synthesis: Exploiting the Versatility of 2-Piperidine Ethanol</article-title><source>Eur. J. Org. Chem.</source><year>2019</year><fpage>4013</fpage><lpage>4019</lpage><pub-id pub-id-type="doi">10.1002/ejoc.201900461</pub-id></element-citation></ref><ref id="B19-molecules-25-01057"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rother</surname><given-names>A.</given-names></name><name><surname>Bobbitt</surname><given-names>J.M.</given-names></name><name><surname>Schwarting</surname><given-names>A.E.</given-names></name></person-group><article-title>Structure and Synthesis of the Alkaloid Anaferine</article-title><source>Chem. Ind.</source><year>1962</year><fpage>654</fpage><lpage>655</lpage></element-citation></ref><ref id="B20-molecules-25-01057"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dar</surname><given-names>N.J.</given-names></name><name><surname>Hamid</surname><given-names>A.</given-names></name><name><surname>Ahmad</surname><given-names>M.</given-names></name></person-group><article-title>Pharmacologic Overview of Withania Somnifera, the Indian Ginseng</article-title><source>Cell. Mol. Life Sci.</source><year>2015</year><volume>72</volume><fpage>4445</fpage><lpage>4460</lpage><pub-id pub-id-type="doi">10.1007/s00018-015-2012-1</pub-id><pub-id pub-id-type="pmid">26306935</pub-id></element-citation></ref><ref id="B21-molecules-25-01057"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Craig</surname><given-names>J.C.</given-names></name><name><surname>Lee</surname><given-names>S.Y.C.</given-names></name><name><surname>Roy</surname><given-names>S.K.</given-names></name></person-group><article-title>Chiroptical Properties of Pelletierine and Anaferine</article-title><source>J. Org. Chem.</source><year>1978</year><volume>43</volume><fpage>347</fpage><lpage>349</lpage><pub-id pub-id-type="doi">10.1021/jo00396a041</pub-id></element-citation></ref><ref id="B22-molecules-25-01057"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>G.</given-names></name><name><surname>Patnaik</surname><given-names>R.</given-names></name></person-group><article-title>Exploring Neuroprotective Potential of Withania Somnifera Phytochemicals by Inhibition of GluN2B-Containing NMDA Receptors: An in Silico Study</article-title><source>Med. Hypotheses</source><year>2016</year><volume>92</volume><fpage>35</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/j.mehy.2016.04.034</pub-id><?supplied-pmid 27241252?><pub-id pub-id-type="pmid">27241252</pub-id></element-citation></ref><ref id="B23-molecules-25-01057"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Remya</surname><given-names>C.</given-names></name><name><surname>Dileep</surname><given-names>K.V.</given-names></name><name><surname>Variayr</surname><given-names>E.J.</given-names></name><name><surname>Sadasivan</surname><given-names>C.</given-names></name></person-group><article-title>An in Silico Guided Identification of NAChR Agonists from Withania Somnifera</article-title><source>Front. Life Sci.</source><year>2016</year><volume>9</volume><fpage>201</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1080/21553769.2016.1207569</pub-id></element-citation></ref><ref id="B24-molecules-25-01057"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blechert</surname><given-names>S.</given-names></name><name><surname>Stapper</surname><given-names>C.</given-names></name></person-group><article-title>Enantioselective Synthesis of (-)-Anaferine Dihydrochloride by a Ruthenium-Catalysed Tandem Ring Rearrangement Metathesis</article-title><source>Eur. J. Org. Chem.</source><year>2002</year><volume>16</volume><fpage>2855</fpage><lpage>2858</lpage><pub-id pub-id-type="doi">10.1002/1099-0690(200208)2002:16&#x0003c;2855::AID-EJOC2855&#x0003e;3.0.CO;2-1</pub-id></element-citation></ref><ref id="B25-molecules-25-01057"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torres</surname><given-names>J.</given-names></name><name><surname>Escolano</surname><given-names>M.</given-names></name><name><surname>Rabasa-Alca&#x000f1;iz</surname><given-names>F.</given-names></name><name><surname>Sanz-Vidal</surname><given-names>A.</given-names></name><name><surname>S&#x000e1;nchez-Rosell&#x000f3;</surname><given-names>M.</given-names></name><name><surname>del Pozo</surname><given-names>C.</given-names></name></person-group><article-title>Highly Convergent Total Synthesis of (+)-Anaferine and (&#x02212;)-Dihydrocuscohygrine</article-title><source>Org. Chem. Front.</source><year>2019</year><volume>6</volume><fpage>3210</fpage><lpage>3214</lpage><pub-id pub-id-type="doi">10.1039/C9QO00811J</pub-id></element-citation></ref><ref id="B26-molecules-25-01057"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rix</surname><given-names>D.</given-names></name><name><surname>Laurent</surname><given-names>I.</given-names></name><name><surname>Boeda</surname><given-names>F.</given-names></name><name><surname>Nolan</surname><given-names>S.P.</given-names></name><name><surname>Mauduit</surname><given-names>M.</given-names></name></person-group><article-title>Aminocarbonyl Group Containing Hoveyda-Grubbs-Type Complexes: Synthesis and Activity in Olefin Metathesis Tranformations</article-title><source>J. Org. Chem.</source><year>2008</year><volume>73</volume><fpage>4225</fpage><lpage>4228</lpage><pub-id pub-id-type="doi">10.1021/jo800203d</pub-id><pub-id pub-id-type="pmid">18459814</pub-id></element-citation></ref><ref id="B27-molecules-25-01057"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winter</surname><given-names>D.K.</given-names></name><name><surname>Drouin</surname><given-names>A.</given-names></name><name><surname>Lessard</surname><given-names>J.</given-names></name><name><surname>Spino</surname><given-names>C.</given-names></name></person-group><article-title>Photochemical Rearrangement of N-Chlorolactams: A Route to N -Heterocycles through Concerted Ring Contraction</article-title><source>J. Org. Chem.</source><year>2010</year><volume>75</volume><fpage>2610</fpage><lpage>2618</lpage><pub-id pub-id-type="doi">10.1021/jo100181h</pub-id><pub-id pub-id-type="pmid">20230016</pub-id></element-citation></ref><ref id="B28-molecules-25-01057"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medda</surname><given-names>A.</given-names></name><name><surname>Lee</surname><given-names>H.-S.</given-names></name></person-group><article-title>3,4-Methano-&#x003b2;-Proline: A Conformationally Constrained &#x003b2;-Amino Acid</article-title><source>Synlett</source><year>2009</year><volume>2009</volume><fpage>921</fpage><lpage>924</lpage><pub-id pub-id-type="doi">10.1055/s-0028-1087965</pub-id></element-citation></ref></ref-list><sec sec-type="display-objects"><title>Figures and Schemes</title><fig id="molecules-25-01057-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Structures of some representative natural piperidine alkaloids, from vegetal and marine origin. The fundamental &#x003b1;-substituted piperidine scaffold, shared by some of them, is highlighted in pink.</p></caption><graphic xlink:href="molecules-25-01057-g001"/></fig><fig id="molecules-25-01057-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Structures of the representative members of our piperidine-based library, obtained through the DOS approach starting from 2-piperidine ethanol.</p></caption><graphic xlink:href="molecules-25-01057-g002"/></fig><fig id="molecules-25-01057-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>(<bold>A</bold>) Retrosynthetic pathway for the synthesis of (-)-anaferine, reported by Stapper and Blechert; (<bold>B</bold>) Retrosynthetic pathway for the synthesis of (+)-anaferine, reported by del Pozo and co-workers.</p></caption><graphic xlink:href="molecules-25-01057-g003"/></fig><fig id="molecules-25-01057-sch001" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-25-01057-sch001_Scheme 1</object-id><label>Scheme 1</label><caption><p>(<bold>A</bold>) Forward synthetic pathway for the generation of the key intermediates <bold>3</bold> and <bold>5</bold>, starting from 2-piperidine ethanol. (<bold>B</bold>) Planning of (-)-anaferine forward synthetic pathway.</p></caption><graphic xlink:href="molecules-25-01057-sch001"/></fig><fig id="molecules-25-01057-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p><sup>1</sup>H-NMR determination of the <italic>d.r.</italic> for the asymmetric allylation of aldehyde <bold>7</bold> (400 MHz, deuterated benzene). (<bold>a</bold>) <sup>1</sup>H-NMR spectra of the reaction mixture for the asymmetric allylation (in blue) and of the two single diastereomers <bold>8</bold> and <bold>8b</bold> (green and red). In the first spectrum the presence of a major and a minor diastereomers is appreciable, as indicated by the two arrows. (<bold>b</bold>) elaboration of the blue spectrum of <xref ref-type="fig" rid="molecules-25-01057-f004">Figure 4</xref>a, showing the integrals exploited for the <italic>d.r.</italic> determination.</p></caption><graphic xlink:href="molecules-25-01057-g004"/></fig><fig id="molecules-25-01057-sch002" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-25-01057-sch002_Scheme 2</object-id><label>Scheme 2</label><caption><p><italic>Reagents and conditions</italic>: (<bold>a</bold>) TBSCl, imidazole, CH<sub>2</sub>Cl<sub>2</sub>, 0 &#x000b0;C to r.t., 5 h, 90%; (<bold>b</bold>) O<sub>3</sub>, PPh<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, &#x02212;78 &#x000b0;C, to r.t., 3 h, 60%; (<bold>c</bold>) (&#x02013;)-allyl-BIpc<sub>2</sub>, THF, &#x02212;78 &#x000b0;C to r.t., 16 h, then H<sub>2</sub>O<sub>2</sub>, NaH<sub>2</sub>PO<sub>4</sub>, MeOH, 0.5 h, 92%, (<bold>d</bold>) PPh<sub>3</sub>, DIAD, DPPA, THF, r.t., 16 h, 85%; (<bold>e</bold>) PPh<sub>3</sub>, THF/H<sub>2</sub>O, 40 &#x000b0;C, 8 h, 80%; (<bold>f</bold>) acryloyl chloride, TEA, CH<sub>2</sub>Cl<sub>2</sub>, 0 &#x000b0;C to r.t., 5 h, 88%; (<bold>g</bold>) M73 SIMes cat. (1 mol %) CH<sub>2</sub>Cl<sub>2</sub>, 50 &#x000b0;C, 5 h, 71%; (<bold>h</bold>) H<sub>2</sub>, Pd/C (10% wt), MeOH, r.t., 16h, quant.; (<bold>i</bold>) Boc<sub>2</sub>O, TEA, DMAP, CH<sub>2</sub>Cl<sub>2</sub>, r.t., 48 h, 82%; (<bold>j</bold>) BH<sub>3</sub> SMe<sub>2</sub>, THF, 0 &#x000b0;C, 5 h, 76%; (<bold>k</bold>) TBAF, THF, &#x02212;15 &#x000b0;C to 0 &#x000b0;C, 16 h, 71%; (<bold>l</bold>) DMP, CH<sub>2</sub>Cl<sub>2</sub>, r.t., 16 h, quant.; (<bold>m</bold>) HCl 4M in dioxane, CH<sub>2</sub>Cl<sub>2</sub>, 0 &#x000b0;C to r.t., 16 h, quant.</p></caption><graphic xlink:href="molecules-25-01057-sch002"/></fig></sec></back></article>